Widmann Financial Services’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.54M Sell
54,870
-48
-0.1% -$1.28K 0.92% 30
2025
Q4
$1.37M Buy
54,918
+1,282
+2% +$32.3K 0.84% 32
2025
Q3
$1.37M Buy
53,636
+107
+0.2% +$2.64K 0.86% 33
2025
Q2
$1.3M Buy
53,529
+205
+0.4% +$4.78K 0.9% 32
2025
Q1
$1.35M Buy
53,324
+2,464
+5% +$64.5K 1.05% 28
2024
Q4
$1.35M Sell
50,860
-408
-0.8% -$11.1K 1.04% 28
2024
Q3
$1.48M Sell
51,268
-481
-0.9% -$14K 1.12% 27
2024
Q2
$1.45M Sell
51,749
-911
-2% -$25.1K 1.18% 26
2024
Q1
$1.46M Buy
52,660
+1,375
+3% +$38.2K 1.23% 28
2023
Q4
$1.48M Sell
51,285
-1,341
-3% -$40.5K 1.33% 23
2023
Q3
$1.75M Buy
52,626
+3,373
+7% +$119K 1.74% 16
2023
Q2
$1.81M Sell
49,253
-2
-0% -$78 1.73% 17
2023
Q1
$2.01M Buy
49,255
+1,885
+4% +$81.4K 2.03% 13
2022
Q4
$2.43M Buy
47,370
+337
+0.7% +$16.2K 2.54% 12
2022
Q3
$2.06M Buy
47,033
+207
+0.4% +$10.1K 2.28% 13
2022
Q2
$2.46M Buy
46,826
+397
+0.9% +$20.2K 2.54% 10
2022
Q1
$2.4M Buy
46,429
+1,365
+3% +$70.8K 2.13% 13
2021
Q4
$2.66M Buy
+45,064
New +$2.23M 2.19% 11

Other funds holding PFE

Widmann Financial Services's PFE Position: Q1 2026 in Review

Widmann Financial Services reduced its Pfizer (PFE) stake by 0.09% in Q1 2026, selling an estimated $1.28K and leaving 54,870 shares worth $1.54M. The position accounts for 0.92% of the portfolio, ranked #30.

Widmann Financial Services first reported a position in PFE in Q4 2021 and has held it in 18 quarters since. The position peaked at $2.66M in Q4 2021. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Widmann Financial Services held 54,870 shares of Pfizer worth $1.54M as of Q1 2026.
  • Widmann Financial Services sold 48 Pfizer shares in Q1 2026, an estimated $1.28K.
  • Pfizer made up 0.92% of Widmann Financial Services's portfolio in Q1 2026, its #30 holding.
  • Widmann Financial Services first reported a position in Pfizer in Q4 2021 and has held it in 18 quarters since.
  • Widmann Financial Services's Pfizer position peaked at $2.66M in Q4 2021.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Widmann Financial Services's 13F filing for Q1 2026, filed 15 May 2026.